Tempus is a brand that has revolutionized the field of precision medicine by building the world's largest library of clinical and molecular data. They have also developed an innovative operating system to make this data easily accessible and useful, with a primary focus on cancer. Their AI-enabled precision medicine approach empowers physicians to make informed treatment decisions by ACCELERATING the discovery of novel targets, PREDICTING the effectiveness of treatments, IDENTIFYING potentially life-saving clinical trials, and DIAGNOSING multiple diseases earlier.

Tempus extends its services to different domains, including Oncology, Neurology & Psychiatry, Cardiology, and Academic & Research Centers. They offer genomic profiling, algorithmic tests, clinical trial matching, digital pathology, financial assistance, and EHR integration solutions. In addition to their extensive services for providers, Tempus also assists pharmaceutical and biotech companies in better drug development.

For patients, Tempus helps in finding unique and optimal therapy options. With their proprietary platform, Tempus has made data accessible and deployed AI at scale. They continuously strive to accelerate and transform personalized patient care through their scientific publications and research projects.

Tempus has collaborated with numerous academic medical centers, oncologists, and pharma companies, and their research data has powered scientific discoveries that improve patient outcomes. They are leading the way toward the future of healthcare with their cutting-edge AI-enabled precision medicine solutions